Spotlight
Strategic buyers’ growing appetite for software — and capital for acquisitions — point to bigger opportunities for investors.
Read More »Companies across the globe are playing an instrumental role in addressing COVID-19 by offering their resources, services and expertise to support customers, employees, partners and local communities. Thoma Bravo’s Portfolio Spotlight Series recognizes some of these efforts and initiatives taking place across our portfolio of companies.
Strategic buyers’ growing appetite for software — and capital for acquisitions — point to bigger opportunities for investors.
Read More »Authored by Holden Spaht
They have a point. While 2023 has been a rebound year for public SaaS companies in growth rates, cost efficiency, and margins, it is still the case that the median public SaaS company loses money. That matters more as the market has shifted from rewarding “growth at all costs” to ”profitable growth,” which appears to be persistent and structural rather than just a short-term cyclical turn. We also hear regularly from public market investors that their SaaS companies never quite reach the free cash flow expectations and margins they target for their investment.
To me, that is not a surprise, as many of the principles required to turn a break-even business into a company with 30% operating margins are not embedded in the company’s operating model. Here’s a back-of-the-envelope calculation on some basic metrics:
Assume the median publicly traded SAAS company has about $700 million in revenue, makes 70% gross margins, has a negative EBITDA, is growing 20%, and trades at about 5.5 NTM revenue (which is roughly what we saw for Q2 2023).
If I buy shares at that multiple and make the following (reasonable) assumptions:
· the company will grow 15% annually for the next six years (a modest deceleration);
· while paying 3% of its float each year as RSUs to employees; and
· trades for 22x NTM EBITDA at the end of year five;
Then, to get a 15% annual return on my investment, I need the company to generate 30% EBITDA margins.
In other words, for me to buy those shares for a five-year hold means placing a bet on a massive improvement in EBITDA margins. In today’s macro-environment with decelerating revenue, it’s a high bar to reach. If the company only hits a 20% EBITDA margin, that gets me a 6% annual return, which is barely above the risk-free Treasury rate.
How can I reasonably determine that the particular company I’m looking at –– among a sea of innovative and compelling software companies — actually has the potential to hit those profitability targets?
In my experience, if you had to choose one financial metric that provides the most relevant information, it would be Gross Revenue Retention (GRR) because it reflects an amalgam of customer satisfaction, competitive positioning, and relative market share.
I find it peculiar that public companies rarely disclose GRR. Even when disclosed, the same definition is not always applied. At Thoma Bravo, we calculate GRR by subtracting downgrades and cancellations over a 12-month period from ARR at the beginning of the corresponding 12-month period for a particular customer cohort and then dividing the result by the ARR from the beginning of the same 12-month period.
In simple terms, we focus on how much revenue a company retains from its customer base over a year — before generating any incremental sales to either new or existing customers. Therefore, the closer a company is to 100 on this measure, the higher quality its revenue stream is. Said another way, high GRR means less reliance on “new bookings” and incremental customer spend to grow, and this typically leads to more predictable revenue over time.
Publicly traded companies are more likely to disclose Net Revenue Retention (NRR) than GRR, using it to speak to the strength of the relationship between the business and the customer. That’s because NRR indicates that a company’s existing customers are expanding their use of their products; they might be buying more seats, features, or other products the company offers. It’s common to hear arguments that NRR around 120% is a rough threshold that signals business strength, even as the median NRR at publicly traded SaaS companies has fallen closer to 110% over the first two quarters of 2023.
However, my concern is about over-indexing on NRR growth, especially given the volatility of NRR year-over-year. Sometimes, businesses that focus on NRR will be the same businesses with relatively low GRR –– think of a young company with multiple products in a secular growth area. If that company had relatively low “up for renewal” rates or GRR (not uncommon), it would imply massive expansion in existing customers’ purchases to sustain the NRR growth.
In my eyes, a high GRR better reflects a durable business model with more substantial long-term profit potential. GRR is a simple indication that customers renew revenue at a very high rate, the opposite of churn. That, in turn, usually means increased customer satisfaction, solid product quality, a strong market position, and pricing power –– all of which are better indicators of business fundamentals.
And those qualities are the same ones that most substantially impact a company’s long-term cash flow margin potential. As we all know, that margin potential is the basis of most investors’ valuation targets. Not having visibility into GRR then becomes a real issue, which raises the question of why investors don’t demand better, more consistent, and transparent disclosure in this area.
In this new era of demand for profitable growth, I imagine most public market investors are asking themselves two main questions about software companies:
(A) Which companies have the potential to become highly profitable businesses while sustaining their organic growth profile; and
(B) Which companies are most likely to achieve those margins?
GRR provides a great basis to begin answering Question A. Question B is more nuanced, as it takes much more than operating leverage to achieve the margins that currently underlie public market valuations.
That nuance drives us at Thoma Bravo –– because transforming “potential” into “reality” is the basis of our investment strategy.
Originally published on LinkedIn
110 N. Wacker Drive
32nd Floor
Chicago, IL 60606
+1 (312) 254-3300
1925 Cedar Springs Road
Suite 205
Dallas, TX 75201
+1 (214) 971-7777
Norfolk House
31 St. James’s Square
6th Floor
London, SW1Y 4JR
UK
830 Brickell Plaza
Suite 5100
Miami, FL 33131
+1 (786) 785-5800
375 Park Avenue
Suite 3603
New York, NY 10022
+1 (212) 292-7070
One Market Plaza
Spear Tower
Suite 2400
San Francisco, CA 94105
+1 (415) 263-3660
Thoma Bravo UK LLP is an Appointed Representative of Sapia Partners LLP which is regulated and authorised by the Financial Conduct Authority (FCA).